Please ensure Javascript is enabled for purposes of website accessibility

Which Company Will Dominate the Teen Vaccination Market This Fall?

By Adria Cimino – Updated Jun 23, 2021 at 7:20AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Teens represent the next big group needing vaccination.

Experts say vaccinating teens and children is a key part of the strategy to beat COVID-19. That's because, like adults, this group also plays a role in spreading the virus. In this Motley Fool Live video recorded on May 28, 2021, healthcare and cannabis bureau editor and analyst Olivia Zitkus and Fool.com contributor Adria Cimino discuss which companies will be ready to vaccinate teens for COVID-19 ahead of the upcoming back-to-school period.

10 stocks we like better than Moderna Inc.
When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.*

David and Tom just revealed what they believe are the ten best stocks for investors to buy right now... and Moderna Inc. wasn't one of them! That's right -- they think these 10 stocks are even better buys.

See the 10 stocks

 

*Stock Advisor returns as of June 7, 2021

 

Olivia Zitkus: When are other vaccine producers planning to submit EUAs (Emergency Use Authorizations) for this age group or for younger kids?

Adria Cimino: Well, first, I'll start with Johnson & Johnson (JNJ). It's a little bit farther behind. They started a teen study last month. We can expect that that's not going to be right away because they're just getting started on this. Moderna (MRNA) really is the closest. They reported positive data just recently, and they said they'll ask the FDA to expand the Emergency Use Authorization in early June to cover teens. I would say it's very possible that both Moderna and Pfizer (PFE) could be out there for the back-to-school vaccination. I'd say that Moderna really is the next one up for this.

Olivia Zitkus owns shares of Moderna Inc. The Motley Fool recommends Johnson & Johnson and Moderna Inc. The Motley Fool has a disclosure policy.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.